Aequus Pharmaceuticals Inc. (AQS.V)
CAD 0.01
(0.0%)
CAD 0.01
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.02 CAD | 7.44% |
| 2022 | -0.02 CAD | -72.86% |
| 2021 | -0.01 CAD | -25.0% |
| 2020 | -0.01 CAD | 70.98% |
| 2019 | -0.04 CAD | -4.04% |
| 2018 | -0.04 CAD | 35.14% |
| 2017 | -0.06 CAD | 42.8% |
| 2016 | -0.10 CAD | 33.33% |
| 2015 | -0.15 CAD | -55.6% |
| 2014 | -0.10 CAD | -26.18% |
| 2013 | -0.08 CAD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.01 CAD | 7.41% |
| 2024 Q2 | -0.01 CAD | -2.0% |
| 2023 Q1 | -0.01 CAD | 27.27% |
| 2023 Q2 | -0.01 CAD | 5.36% |
| 2023 Q4 | -0.01 CAD | 11.48% |
| 2023 Q3 | -0.01 CAD | -15.09% |
| 2023 FY | - CAD | 7.44% |
| 2022 Q4 | -0.01 CAD | -102.63% |
| 2022 Q2 | -0.01 CAD | 15.94% |
| 2022 Q1 | -0.01 CAD | -176.0% |
| 2022 FY | - CAD | -72.86% |
| 2022 Q3 | -0.00 CAD | 34.48% |
| 2021 Q2 | -0.00 CAD | 32.08% |
| 2021 Q4 | -0.00 CAD | 13.79% |
| 2021 FY | - CAD | -25.0% |
| 2021 Q1 | -0.01 CAD | -253.33% |
| 2021 Q3 | -0.00 CAD | 19.44% |
| 2020 FY | - CAD | 70.98% |
| 2020 Q3 | -0.00 CAD | 10.71% |
| 2020 Q2 | -0.00 CAD | 44.0% |
| 2020 Q1 | -0.01 CAD | 61.24% |
| 2020 Q4 | -0.00 CAD | 40.0% |
| 2019 Q2 | -0.01 CAD | 7.69% |
| 2019 FY | - CAD | -4.04% |
| 2019 Q3 | -0.01 CAD | 2.38% |
| 2019 Q1 | -0.01 CAD | -9.64% |
| 2019 Q4 | -0.01 CAD | -57.32% |
| 2018 Q4 | -0.01 CAD | 1.19% |
| 2018 FY | - CAD | 35.14% |
| 2018 Q2 | -0.01 CAD | 18.58% |
| 2018 Q3 | -0.01 CAD | 8.7% |
| 2018 Q1 | -0.01 CAD | -25.56% |
| 2017 Q1 | -0.02 CAD | 18.52% |
| 2017 FY | - CAD | 42.8% |
| 2017 Q4 | -0.01 CAD | 32.33% |
| 2017 Q3 | -0.01 CAD | 25.7% |
| 2017 Q2 | -0.02 CAD | -1.7% |
| 2016 Q1 | -0.03 CAD | 34.25% |
| 2016 FY | - CAD | 33.33% |
| 2016 Q2 | -0.03 CAD | -17.87% |
| 2016 Q4 | -0.02 CAD | 7.69% |
| 2016 Q3 | -0.02 CAD | 24.52% |
| 2015 Q1 | -0.04 CAD | 26.6% |
| 2015 Q4 | -0.04 CAD | -5.82% |
| 2015 FY | - CAD | -55.6% |
| 2015 Q3 | -0.04 CAD | -3.56% |
| 2015 Q2 | -0.04 CAD | 6.17% |
| 2014 Q4 | -0.05 CAD | -208.14% |
| 2014 FY | - CAD | -26.18% |
| 2014 Q3 | -0.02 CAD | -72.0% |
| 2014 Q1 | -0.01 CAD | 34.59% |
| 2014 Q2 | -0.01 CAD | 3.85% |
| 2013 FY | - CAD | 0.0% |
| 2013 Q4 | -0.02 CAD | -55.88% |
| 2013 Q3 | -0.01 CAD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| CanadaBis Capital Inc. | 0.03 CAD | 169.136% |
| Decibel Cannabis Company Inc. | -0.00 CAD | -420.93% |
| Delivra Health Brands Inc. | 0.00 CAD | 822.581% |
| Entourage Health Corp. | -0.15 CAD | 85.067% |
| Lifeist Wellness Inc. | -0.58 CAD | 96.138% |
| Cannara Biotech Inc. | 0.08 CAD | 128.792% |
| Medicure Inc. | -0.09 CAD | 74.632% |
| PharmaCielo Ltd. | -0.10 CAD | 77.6% |
| Rubicon Organics Inc. | -0.03 CAD | 30.65% |
| BioSyent Inc. | 0.54 CAD | 104.148% |
| Voyageur Pharmaceuticals Ltd. | -0.01 CAD | -109.346% |